Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


McCamish Mark Anthony Create: Alert

All | News | Filings
Date FiledTypeDescription
08/15/2023 4 McCamish Mark Anthony (Director) has filed a Form 4 on AVADEL PHARMACEUTICALS PLC
Txns: Sold 28,975 shares @ $14.9306, valued at $432.6k
08/03/2023 4 McCamish Mark Anthony (Director) has filed a Form 4 on AVADEL PHARMACEUTICALS PLC
Txns: Granted 33,000 options to buy @ $14.1, valued at $465.3k
01/05/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/05/2022 4 McCamish Mark Anthony (Director) has filed a Form 4 on Rafael Holdings, Inc.
Txns: Granted 5,412 shares @ $5.39, valued at $29.2k
08/05/2021 4 McCamish Mark Anthony (Director) has filed a Form 4 on AVADEL PHARMACEUTICALS PLC
Txns: Granted 42,000 options to buy @ $8.07, valued at $338.9k
06/22/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
12/28/2020 4 McCamish Mark Anthony (Director) has filed a Form 4 on Vincera Pharma, Inc.
Txns: Granted 6,667 options to buy @ $19, valued at $126.7k
12/28/2020 3 McCamish Mark Anthony (Director) has filed a Form 3 on Vincera Pharma, Inc.
09/18/2020 4 McCamish Mark Anthony (Director) has filed a Form 4 on AVADEL PHARMACEUTICALS PLC
Txns: Bought 118,602 shares @ $5.7332, valued at $680k
Bought 52,398 shares @ $5.8256, valued at $305.2k
09/14/2020 4 McCamish Mark Anthony (Director) has filed a Form 4 on AVADEL PHARMACEUTICALS PLC
Txns: Granted 50,000 options to buy @ $5.3, valued at $265k
08/11/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/07/2020 4 McCamish Mark Anthony (President and CEO) has filed a Form 4 on Forty Seven, Inc.
Txns: Disposed/sold 4,595 shares @ $0
Disposed/sold 314,395 options to buy @ $4.8825, valued at $1.5M
Disposed/sold 134,629 options to buy @ $4.8825, valued at $657.3k
Disposed/sold 334,239 options to buy @ $5.27, valued at $1.8M
Disposed/sold 184,516 options to buy @ $8.7575, valued at $1.6M
Disposed/sold 327,375 options to buy @ $35.75, valued at $11.7M
04/03/2020 4 McCamish Mark Anthony (President and CEO) has filed a Form 4 on Forty Seven, Inc.
Txns: Gifted 60,719 shares @ $0
Sold 2,340 shares @ $95.4138, valued at $223.3k
Sold 30,237 shares @ $95.4207, valued at $2.9M
Exercised 30,210 options to buy @ $4.8825, valued at $147.5k
Exercised 27 options to buy @ $4.8825, valued at $131.8
12/17/2019 4 McCamish Mark Anthony (President and CEO) has filed a Form 4 on Forty Seven, Inc.
Txns: Granted 327,375 options to buy @ $35.75, valued at $11.7M
12/09/2019 4 McCamish Mark Anthony (Director) has filed a Form 4 on AVADEL PHARMACEUTICALS PLC
Txns: Granted 60,000 options to buy @ $5.92, valued at $355.2k
12/09/2019 3 McCamish Mark Anthony (Director) has filed a Form 3 on AVADEL PHARMACEUTICALS PLC
06/27/2019 4 McCamish Mark Anthony (President and CEO) has filed a Form 4 on Forty Seven, Inc.
Txns: Sold 8,199 shares @ $11.0246, valued at $90.4k
Exercised 8,199 options to buy @ $4.8825, valued at $40k
06/24/2019 4 McCamish Mark Anthony (President and CEO) has filed a Form 4 on Forty Seven, Inc.
Txns: Sold 8,301 shares @ $11.038, valued at $91.6k
Exercised 8,301 options to buy @ $4.8825, valued at $40.5k
05/22/2019 4 McCamish Mark Anthony (President and CEO) has filed a Form 4 on Forty Seven, Inc.
Txns: Sold 15,209 shares @ $12.0748, valued at $183.6k
Sold 1,291 shares @ $12.4555, valued at $16.1k
Exercised 15,209 options to buy @ $4.8825, valued at $74.3k
Exercised 1,291 options to buy @ $4.8825, valued at $6.3k
04/22/2019 4 McCamish Mark Anthony (President and CEO) has filed a Form 4 on Forty Seven, Inc.
Txns: Sold 16,500 shares @ $18.1245, valued at $299.1k
Exercised 16,500 options to buy @ $4.8825, valued at $80.6k
03/21/2019 4 McCamish Mark Anthony (President and CEO) has filed a Form 4 on Forty Seven, Inc.
Txns: Sold 16,500 shares @ $18.1455, valued at $299.4k
Exercised 16,500 options to buy @ $4.8825, valued at $80.6k
02/21/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/29/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/23/2019 4 McCamish Mark Anthony (President and CEO) has filed a Form 4 on Forty Seven, Inc.
Txns: Sold 20,000 shares @ $14.5946, valued at $291.9k
Exercised 16,500 options to buy @ $4.8825, valued at $80.6k
Exercised 3,500 options to buy @ $4.8825, valued at $17.1k
12/28/2018 4 McCamish Mark Anthony (President and CEO) has filed a Form 4 on Forty Seven, Inc.
Txns: Sold 9,032 shares @ $15.9041, valued at $143.6k
Sold 2,968 shares @ $15.8895, valued at $47.2k
Exercised 9,032 options to buy @ $4.8825, valued at $44.1k
Exercised 2,968 options to buy @ $4.8825, valued at $14.5k
06/27/2018 3 McCamish Mark Anthony (President and CEO) has filed a Form 3 on Forty Seven, Inc.
04/06/2009 4 Form 4 - Statement of changes in beneficial ownership of securities
02/23/2009 4 McCamish Mark Anthony (Sr. VP & Chief Medical Officer) has filed a Form 4 on FACET BIOTECH CORP
01/27/2009 4 McCamish Mark Anthony (Sr. VP & Chief Medical Officer) has filed a Form 4 on FACET BIOTECH CORP
12/19/2008 3 McCamish Mark Anthony (Sr. VP & Chief Medical Officer) has filed a Form 3 on FACET BIOTECH CORP
12/19/2008 4 McCamish Mark Anthony (SVP & CMO) has filed a Form 4 on PDL BIOPHARMA, INC.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy